M
MediCrops
Biotech & Life Sciences · Freienbach, Switzerland · Founded 2019
Health-tech firm specializing in medical cannabis distribution and digital patient care via telemedicine MoreLess
MediCrops AG is a health-tech company specializing in the distribution and advancement of medical cannabis therapies, with a strong focus on digital innovation and telemedicine. Operating in both Switzerland and Germany, MediCrops is not only a supplier but also an active developer of new healthcare solutions, aiming to reshape patient care through technology. The company leverages a network of medical professionals specializing in cannabis-based treatments to provide patients with direct access to personalized therapies via digital platforms. MediCrops has expanded its infrastructure by acquiring its own pharmacy and medical practice, further integrating its services and enhancing its capacity to deliver tailored healthcare solutions. The company is committed to revolutionizing access to new treatment methods and continuously expanding its presence in the digital health sector.
Keywords: MediCrops, medical cannabis, health-tech, telemedicine, digital health, patient care, Switzerland, Germany, personalized therapy, healthcare innovation, pharmacy, medical practice, cannabis therapy, digital therapy, healthcare network
Company overview
MediCrops company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2019
- Headquarters
- Freienbach, Switzerland
- Employees
- 12
- Open positions
- None listed
- Dealroom signal
- 51.7
- Investment activity
- 3 companies · latest Jan 2024
- Capital deployed
- —
- Preferred round
- ACQUISITION
Valuation & funding
MediCrops funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Aug 2022 | $3.4M | $92M | Undisclosed | ↗ |
| LATE VC✓Equity / VC | Jan 2021 | $18M | $73M | Undisclosed | ↗ |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 9 |
| 2025 | 11 |
| 2024 | 10 |
| 2023 | 7 |
| 2022 | 9 |
Growth signals
MediCrops website traffic
Latest recorded traffic for MediCrops is 460 monthly website visits, down 72.9% over the last three months. MediCrops's team grew 9.1% over the past year.
Comparisons
MediCrops compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Capital deployed
MediCrops investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
topmed PraxenBasel, Switzerland
→
ToppharmMünchenstein, Switzerland
→
Swiss AlpinopharmaBerlin, GermanyEvidence-based cannabinoid treatment for the health of patients
→
Talent graph
MediCrops's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where MediCrops has talent and traffic
In the news
Latest news about MediCrops
Recent press, funding announcements, and product moves mentioning MediCrops — open to read from the original sources.
Market sentiment
What the market is saying about MediCrops
An AI-synthesized read of the highest-engagement posts about MediCrops on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MediCrops’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.